BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15864528)

  • 1. Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats.
    Hattori Y; Akimoto K; Gross SS; Hattori S; Kasai K
    Diabetologia; 2005 Jun; 48(6):1066-74. PubMed ID: 15864528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrahydrobiopterin prevents endothelial dysfunction and restores adiponectin levels in rats.
    Wang X; Hattori Y; Satoh H; Iwata C; Banba N; Monden T; Uchida K; Kamikawa Y; Kasai K
    Eur J Pharmacol; 2007 Jan; 555(1):48-53. PubMed ID: 17098227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementation with tetrahydrobiopterin prevents the cardiovascular effects of angiotensin II-induced oxidative and nitrosative stress.
    Kase H; Hashikabe Y; Uchida K; Nakanishi N; Hattori Y
    J Hypertens; 2005 Jul; 23(7):1375-82. PubMed ID: 15942460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
    Whaley-Connell A; Govindarajan G; Habibi J; Hayden MR; Cooper SA; Wei Y; Ma L; Qazi M; Link D; Karuparthi PR; Stump C; Ferrario C; Sowers JR
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E355-63. PubMed ID: 17440033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.
    Hirono Y; Yoshimoto T; Suzuki N; Sugiyama T; Sakurada M; Takai S; Kobayashi N; Shichiri M; Hirata Y
    Endocrinology; 2007 Apr; 148(4):1688-96. PubMed ID: 17218415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension.
    Zheng JS; Yang XQ; Lookingland KJ; Fink GD; Hesslinger C; Kapatos G; Kovesdi I; Chen AF
    Circulation; 2003 Sep; 108(10):1238-45. PubMed ID: 12925450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.
    Rugale C; Delbosc S; Mimran A; Jover B
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):293-8. PubMed ID: 17878758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tempol on endothelial and vascular dysfunctions and insulin resistance induced by a high-fat high-sucrose diet in the rat.
    Bourgoin F; Bachelard H; Badeau M; Larivière R; Nadeau A; Pitre M
    Can J Physiol Pharmacol; 2013 Jul; 91(7):547-61. PubMed ID: 23826653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta(1) Receptors protect the renal afferent arteriole of angiotensin-infused rabbits from norepinephrine-induced oxidative stress.
    Wang D; Jose P; Wilcox CS
    J Am Soc Nephrol; 2006 Dec; 17(12):3347-54. PubMed ID: 17108317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.
    Rosón MI; Della Penna SL; Cao G; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
    J Cell Physiol; 2010 Jul; 224(1):41-8. PubMed ID: 20232302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
    Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
    Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse model of angiotensin II slow pressor response: role of oxidative stress.
    Kawada N; Imai E; Karber A; Welch WJ; Wilcox CS
    J Am Soc Nephrol; 2002 Dec; 13(12):2860-8. PubMed ID: 12444204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
    Elmarakby AA; Williams JM; Imig JD; Pollock JS; Pollock DM
    Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension.
    Hernanz R; Martínez-Revelles S; Palacios R; Martín A; Cachofeiro V; Aguado A; García-Redondo L; Barrús MT; de Batista PR; Briones AM; Salaices M; Alonso MJ
    Br J Pharmacol; 2015 Jun; 172(12):3159-76. PubMed ID: 25712370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA; Mann G; Walton M; Eatman D
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency.
    Vaziri ND; Dicus M; Ho ND; Boroujerdi-Rad L; Sindhu RK
    Kidney Int; 2003 Jan; 63(1):179-85. PubMed ID: 12472781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling.
    Ogihara T; Asano T; Ando K; Chiba Y; Sakoda H; Anai M; Shojima N; Ono H; Onishi Y; Fujishiro M; Katagiri H; Fukushima Y; Kikuchi M; Noguchi N; Aburatani H; Komuro I; Fujita T
    Hypertension; 2002 Dec; 40(6):872-9. PubMed ID: 12468572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
    Satoh M; Fujimoto S; Haruna Y; Arakawa S; Horike H; Komai N; Sasaki T; Tsujioka K; Makino H; Kashihara N
    Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1144-52. PubMed ID: 15687247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
    Banday AA; Lokhandwala MF
    Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.